STOCK TITAN

ASAIY lifts capital via 60,751-share stock option exercises

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Sendas Distribuidora S.A. reported a small capital increase tied to its employee stock option plan. The board approved the issuance of 60,751 common shares at an issuance price of R$0.01 per share, arising from option exercises in Series B10 (41,225 shares) and Series B11 (19,526 shares).

Total capital rose by R$607.51, moving the Company’s capital stock from R$1,455,782,010.46 to R$1,455,782,617.97. The new shares carry the same rights as existing common shares. The stock option plan was originally approved on December 31, 2020. The Company states a dilution percentage of -0.0044884474989071%.

Positive

  • None.

Negative

  • None.

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

_____________________

 

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or

15d-16 of the Securities Exchange Act of 1934

For the month of November 2025

Commission File Number: 001-39928

_____________________

 

Sendas Distribuidora S.A.

(Exact Name as Specified in its Charter)

Sendas Distributor S.A.

(Translation of registrant’s name into English)

Avenida Ayrton Senna, No. 6,000, Lote 2, Pal 48959, Anexo A

Jacarepaguá

22775-005 Rio de Janeiro, RJ, Brazil

(Address of principal executive offices)

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)

Form 20-F:   ý
      Form 40-F:   o

 
 

 

 

SENDAS DISTRIBUIDORA S.A.

Tax ID (“CNPJ/MF”) 06.057.223/0001-71

NIRE 3330027290-9

 

 

 

 

 

 

INFORMATION ON THE CAPITAL INCREASE DUE TO THE COMPANY’S STOCK OPTION PLAN, APPROVED BY THE BOARD OF DIRECTORS IN THE MEETING HELD ON NOVEMBER 6th, 2025.

 

 

 

 
 

 

 

In compliance with article 33, XXXI of CVM Resolution No 80/22, as amended, Sendas Distribuidora S.A. ( “Company”) hereby provides the information required in the Exhibit E of such Resolution, regarding the capital increase approved by the Company’s Board of Directors on November 6th, 2025, due to the exercise of stock options granted to certain employees under the Company’s stock option plans, as follows:

 

1.       Date of the shareholders meeting in which the stock option plan was approved

 

On December 31st, 2020, our shareholders approved, in an Extraordinary Shareholders Meeting, the creation of the Stock Option Plan (“Stock Option Plan”).

 

2.       Amount of the capital increase and new capital stock


The approved capital increase is R$ 607.51 (six hundred and seven reais and fifty-one cents).

 

After the increase, the Company’s capital stock will be changed from the current R$ 1,455,782,010.46 (one billion, four hundred and fifty-five million, seven hundred and eighty-two thousand, ten reais and forty-six cents) to R$ 1,455,782,617.97 (one billion, four hundred and fifty-five million, seven hundred and eighty-two thousand, six hundred and seventeen reais and ninety-seven cents).

 

3.       Number of shares issued of each type and class

 

The capital increase was approved by means of the issuance of 60,751 (sixty thousand, seven hundred and fifty-one) common shares.

 

In accordance with the Company’s Bylaws, such common shares issued have the same characteristics, conditions and are granted the same rights, benefits and advantages of other existing common shares issued by the Company, including dividends and other capital’s remuneration that may be declared by the Company.

 

4.       Issuance price of the new shares

 

(i)       Exercise of Series B10: 41,225 (forty-one thousand, two hundred and twenty-five) common shares, at the issuance price of R$0.01 (one cent) per share; and

(ii)       Exercise of Series B11: 19.526 (nineteen thousand, five hundred and twenty-six) common shares, at the issuance price of R$0.01 (one cent) per share.

 

5.       Percentage of potential dilution resulting from the issuance

 

Percentage of dilution of -0,0044884474989071%.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: November 6, 2025

Sendas Distribuidora S.A.

 

By: /s/ Aymar Giglio Junior

Name: Aymar Giglio Junior

Title: Vice President of Finance

 

 

By: /s/ Gabrielle Helú

Name: Gabrielle Helú

Title: Investor Relations Officer

 

 

FORWARD-LOOKING STATEMENTS

 

This press release may contain forward-looking statements. These statements are statements that are not historical facts, and are based on management's current view and estimates of future economic circumstances, industry conditions, company performance and financial results. The words "anticipates", "believes", "estimates", "expects", "plans" and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the declaration or payment of dividends, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of management and are subject to a number of risks and uncertainties. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors could cause actual results to differ materially from current expectations.

 

FAQ

What did ASAIY disclose in this 6-K?

A capital increase from employee stock option exercises, issuing 60,751 common shares at R$0.01 per share.

How much did Sendas Distribuidora’s capital stock increase by?

By R$607.51, from R$1,455,782,010.46 to R$1,455,782,617.97.

Which option series were exercised and how many shares?

Series B10: 41,225 shares; Series B11: 19,526 shares.

When was the stock option plan approved?

On December 31, 2020, at an Extraordinary Shareholders Meeting.

Do the new shares have the same rights as existing ones?

Yes. The new common shares have the same characteristics, rights, and benefits as existing common shares.

What dilution percentage did the company state?

The Company stated a dilution percentage of -0.0044884474989071%.